US Patent 11186628 RSV-specific antibodies and functional parts thereof
Patent 11186628 was granted and assigned to MedImmune on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 1, 2020
Date of Patent
November 30, 2021
Patent Applicant
Patent Application Number
16864454
Patent Citations Received
Patent Inventor Names
Andy Q. Yuan
0
Bettina Richter
0
Nancy Ulbrandt
0
Nicole Kallewaard-Lelay
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11186628 RSV-specific antibodies and functional parts thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.